Tues., September 19, 2017 | 10:00-11:15 a.m. CT | Live MBHB Webinar via WebEx
Since becoming available nearly 5 years ago, inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB) have become an increasingly popular mechanism to challenge bio/pharma patents. Both petitioners and patent owners can learn lessons from the hundreds of IPR petitions that have been filed challenging bio/pharma patents.
Join us as we discuss the following topics:
MBHB partners Alison Baldwin and Paula Fritsch, Ph.D.
NOTE: MCLE credit is not available for this archived recording.
McDonnell Boehnen Hulbert & Berghoff LLP is committed to educating clients and friends of the firm with respect to significant developments and trends in the areas of intellectual property law.